Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.610
+0.070 (2.76%)
At close: Apr 2, 2025, 4:00 PM
2.576
-0.034 (-1.30%)
After-hours: Apr 2, 2025, 6:00 PM EDT

Cyclerion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
7882975104
Upgrade
Market Cap Growth
-0.51%-0.51%-71.30%-61.69%-28.31%39.09%
Upgrade
Enterprise Value
45-181684
Upgrade
Last Close Price
2.543.223.3513.1234.4061.20
Upgrade
PS Ratio
3.204.08-96.1018.9045.26
Upgrade
PB Ratio
0.730.920.732.731.541.75
Upgrade
P/TBV Ratio
0.920.920.732.731.541.75
Upgrade
EV/Sales Ratio
1.762.64-27.393.9336.37
Upgrade
Debt / Equity Ratio
-----0.77
Upgrade
Asset Turnover
0.170.17-0.010.050.02
Upgrade
Quick Ratio
5.235.233.631.774.883.22
Upgrade
Current Ratio
5.835.833.851.945.003.45
Upgrade
Return on Equity (ROE)
-30.36%-30.36%-115.85%-62.17%-95.87%-98.97%
Upgrade
Return on Assets (ROA)
-19.76%-19.76%-38.34%-29.94%-38.86%-34.34%
Upgrade
Return on Capital (ROIC)
-22.52%-22.52%-55.47%-39.48%-44.24%-37.44%
Upgrade
Earnings Yield
-45.31%-37.51%-64.25%-154.44%-69.32%-74.87%
Upgrade
FCF Yield
-64.22%-53.17%-259.37%-142.29%-49.02%-71.22%
Upgrade
Buyback Yield / Dilution
-7.70%-7.70%-7.59%-11.03%-28.75%-11.04%
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q